NCT04907318

Brief Summary

The primary objective of the study is to observe the rotational stability of the implant 30 minutes, one day, 6 weeks, 6 months and 12 months after the implant surgery. In addition, the refraction will be measured as it is directly affected in the event of postoperative rotation. The correlation between postoperative rotation and the following parameters will be determined: PEXS, white-to-white, age, axial length, anterior chamber depth. Visual acuities with and without correction and the best refraction to assess the benefit of the implants will also be investigated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2016

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2016

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2016

Completed
4.9 years until next milestone

First Submitted

Initial submission to the registry

May 25, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 28, 2021

Completed
Last Updated

June 2, 2021

Status Verified

May 1, 2021

Enrollment Period

5 months

First QC Date

May 25, 2021

Last Update Submit

May 28, 2021

Conditions

Keywords

IOLToricMultifocal

Outcome Measures

Primary Outcomes (1)

  • To observe the rotational stability of the implant

    Observation of rotational stability of the implant

    6 Months

Secondary Outcomes (1)

  • Visual Acuity

    6 Months

Study Arms (2)

ANKORIS

Cataract surgery performed with POD26PAYT

Device: Cataract surgery

FINEVISION TORIC

Cataract surgery performed with POD26PAYFT

Device: Cataract surgery

Interventions

ANKORISFINEVISION TORIC

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This retrospective study will include approximately 90 eyes of patients (adults) receiving conventional cataract surgery having a preoperative corneal astigmatism of 1.0 D or higher and had been implanted with the Ankoris or T-Flex or FineVision toric implant (about 30/30 and20). So that the groups are comparable, the inclusion and exclusion criteria will be those applicable to a multifocal implant.

You may qualify if:

  • Cataract (with or without presbyopia)
  • No pre-existing ocular pathology or history of ocular surgery
  • No phacodonesis
  • PEX patients (pseudoexfoliation syndrome) can be included.

You may not qualify if:

  • To ensure equivalence of the two comparable groups, the patients with potential postoperative visual acuity less than 5/10, particularly due to an insufficient retinal function or poor corneal condition will be excluded.
  • In particular the patients with the following pathologies will be excluded:
  • Irregular astigmatism.
  • Cases of uncontrolled glaucoma.
  • Intraocular inflammation.
  • Narrow anterior chambers (2.5 mm).
  • Amblyopia with potential visual acuity less than 5/10.
  • Any corneal pathology potentially affecting topography (e.g., keratoconus).
  • Patients with a history of corneal surgery (especially refractive surgery).
  • Patients with diagnosed degenerative visual disorders (e.g., macular degeneration, diabetic retinopathy or other retina diseases or surgery) with known negative impact on visual function possibly leading to visual acuity levels below 0.5.
  • Patients with a history of ocular trauma.
  • Pathological miosis.
  • Patients with zonular laxity.
  • Patients suffering from chronic uveitis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vista Alpina Eye Center

Visp, 3930, Switzerland

Location

MeSH Terms

Conditions

Cataract

Interventions

Cataract Extraction

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Intervention Hierarchy (Ancestors)

Refractive Surgical ProceduresOphthalmologic Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Kristof Vandekerckhove, MD

    Vista Alpina Eye Cente, Visp, Switzerland, 3930

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 25, 2021

First Posted

May 28, 2021

Study Start

January 1, 2016

Primary Completion

June 1, 2016

Study Completion

July 1, 2016

Last Updated

June 2, 2021

Record last verified: 2021-05

Locations